With the vaccine market registering increased growth rates across the pharmaceutical and biotechnology industries, it is critical to partner with a company that has expertise across the development process to get the safest and most effective vaccines to market. Charles River has consistently and effectively supported the vaccine industry for decades with its unique range of products and related services. Working with our global network of scientific, technical and regulatory experts provides vaccine developers with the right expertise early in the development process to boost productivity, efficiency and profitability.
Capabilities to Support Development and Commercialization of Vaccines
Related Information
For a copy of our Preclinical Vaccine Researcher newsletter and access to our archived vaccine webinars, please log in to The SourceSM. If you are not a member of The SourceSM, our new online scientific and educational information center, please click here to register.
For more information on our capabilities that help support the development and commercialization of vaccines, contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.